AdvaMed®
  • Our Work
    • Key Issues
    • Policy Areas
    • Sectors
    • Emerging Policy & Tariff Response Center
    • Annual Report
  • Industry Updates
    • Research & Policy Papers
    • Medtech POV with Scott Whitaker
    • Medtech POV Blog
    • Press Releases
  • Join
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events & Education
    • All Events & Education
    • In Person
    • Online
Login
Coverage & Payment

AdvaMed® Comment on CMS’s NCA On Artificial Hearts and Related Devices

Coverage & Payment

AdvaMed® Comment on Medicare End-Stage Renal Disease Prospective Payment System Final Rule

Ethylene Oxide

AdvaMed® Comments on National Emission Standards for Hazardous Air Pollutants: Miscellaneous Organic Chemical Manufacturing Residual Risk and Technology Review

AdvaMed® provided these comments in response to the U.S. Environmental Protection Agency (EPA) publishing the proposed rulemaking concerning the residual risk and technology review (RTR) for the National Emission Standards…

Ethylene Oxide

AdvaMed® Comments on National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Commercial Sterilization and Fumigation Operations

AdvaMed® provided these comments in response to the U.S. Environmental Protection Agency (EPA) soliciting information that will aid in potential future revisions to the Ethylene Oxide Emission Standards for Sterilization…

Coverage & Payment

AdvaMed® Comments to National Clinical Care Commission

Coverage & Payment / Legal / Value-Based Collaborations

Dec. 31, 2019 AdvaMed® Comments on CMS Value-Based Physician Self-Referral Exception Proposed Rules

Legal

December 24, 2019 AdvaMed® Comments on OIG Value-Based AKS Safe Harbor Proposed Rules

Ethylene Oxide

AdvaMed® Letter to EPA on Ethylene Oxide

Ethylene Oxide

AdvaMed® Comments to Texas Commission on Environmental Quality on Exposure Assessment

Ethylene Oxide

AdvaMed® Comments to the Chemical Assessment Advisory Committee for the Integrated Risk Information System Evaluation of the Inhalation Carcinogenicity of Ethylene Oxide

  • Previous
  • 1
  • 2
  • 3
  • Next
AdvaMed®

Stay up to date with AdvaMed®.

Subscribe for Updates
  • Join
  • Member Center
  • Industry Updates
  • Contact
  • FAQs
  • Events & Education
  • Careers
  • The Story of Medtech
  • The Medtech Conference
  • Because Every Moment Matters 

Copyright 2025 AdvaMed®

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Accessibility Statement
  • 中文
  • youtube
  • linkedin
  • facebook
  • X
  • medium
  • instagram

Menu

  • Our Work
    • Key Issues
    • Policy Areas
    • Sectors
    • Emerging Policy & Tariff Response Center
    • Annual Report
  • Industry Updates
    • Research & Policy Papers
    • Medtech POV with Scott Whitaker
    • Medtech POV Blog
    • Press Releases
  • Join
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events & Education
    • All Events & Education
    • In Person
    • Online
  • Login
  • About AdvaMed®
    • Our Leadership
    • Initiatives
    • Jobs at AdvaMed®
    • Contact Us
  • Membership & Join
    • Membership Directory
    • Associate Membership Directory
    • Membership Application
    • Lifetime Achievement Award
  • Medical Device Industry Facts
    • Safety & Quality
    • Job Creation
  • AdvaMed Accel®
    • Accel Member Directory
    • Partnerships and Opportunities
  • AdvaMedDx®
    • AdvaMed®DX Members
    • AdvaMedDx® Resources
    • Join AdvaMed®DX
  • AdvaMed Digital Health Tech™
    • AdvaMed Digital Health Tech™ Members
  • AdvaMed Medical Imaging™
    • AdvaMed Imaging® Members

Search